Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1937 1
1940 1
1958 2
1960 5
1962 5
1963 6
1964 3
1965 5
1966 2
1967 1
1968 1
1969 3
1970 7
1971 5
1972 8
1973 5
1974 6
1975 14
1976 10
1977 10
1978 9
1979 8
1980 14
1981 11
1982 18
1983 21
1984 16
1985 12
1986 29
1987 24
1988 20
1989 14
1990 20
1991 33
1992 36
1993 23
1994 24
1995 34
1996 24
1997 34
1998 53
1999 57
2000 62
2001 61
2002 66
2003 88
2004 104
2005 99
2006 150
2007 184
2008 184
2009 199
2010 227
2011 253
2012 334
2013 358
2014 341
2015 385
2016 470
2017 493
2018 514
2019 560
2020 645
2021 729
2022 881
2023 772
2024 812
2025 448

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,064 results

Results by year

Filters applied: . Clear all
Page 1
DDX3X: structure, physiologic functions and cancer.
Mo J, Liang H, Su C, Li P, Chen J, Zhang B. Mo J, et al. Among authors: su c. Mol Cancer. 2021 Feb 24;20(1):38. doi: 10.1186/s12943-021-01325-7. Mol Cancer. 2021. PMID: 33627125 Free PMC article. Review.
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Su C, Sands BE, D'Haens GR, Vermeire S, Schreiber S, Danese S, Feagan BG, Reinisch W, Niezychowski W, Friedman G, Lawendy N, Yu D, Woodworth D, Mukherjee A, Zhang H, Healey P, Panés J; OCTAVE Induction 1, OCTAVE Induction 2, and OCTAVE Sustain Investigators. Sandborn WJ, et al. Among authors: su c. N Engl J Med. 2017 May 4;376(18):1723-1736. doi: 10.1056/NEJMoa1606910. N Engl J Med. 2017. PMID: 28467869 Free article. Clinical Trial.
Single-cell transcriptomic and proteomic analysis of Parkinson's disease brains.
Zhu B, Park JM, Coffey SR, Russo A, Hsu IU, Wang J, Su C, Chang R, Lam TT, Gopal PP, Ginsberg SD, Zhao H, Hafler DA, Chandra SS, Zhang L. Zhu B, et al. Among authors: su c. Sci Transl Med. 2024 Oct 30;16(771):eabo1997. doi: 10.1126/scitranslmed.abo1997. Epub 2024 Oct 30. Sci Transl Med. 2024. PMID: 39475571
Stem-like memory and precursors of exhausted T cells share a common progenitor defined by ID3 expression.
Gago da Graça C, Sheikh AA, Newman DM, Wen L, Li S, Shen J, Zhang Y, Gabriel SS, Chisanga D, Seow J, Poch A, Rausch L, Nguyen MT, Singh J, Su CH, Cluse LA, Tsui C, Burn TN, Park SL, Von Scheidt B, Mackay LK, Vasanthakumar A, Bending D, Shi W, Cui W, Schröder J, Johnstone RW, Kallies A, Utzschneider DT. Gago da Graça C, et al. Among authors: su ch. Sci Immunol. 2025 Jan 31;10(103):eadn1945. doi: 10.1126/sciimmunol.adn1945. Epub 2025 Jan 31. Sci Immunol. 2025. PMID: 39888981 Free PMC article.
Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease.
Yoshiji S, Lu T, Butler-Laporte G, Carrasco-Zanini-Sanchez J, Su CY, Chen Y, Liang K, Willett JDS, Wang S, Adra D, Ilboudo Y, Sasako T, Koyama S, Nakao T, Forgetta V, Farjoun Y, Zeberg H, Zhou S, Marks-Hultström M, Machiela MJ, Kaalia R, Dashti H, Claussnitzer M, Flannick J, Wareham NJ, Mooser V, Timpson NJ, Langenberg C, Richards JB. Yoshiji S, et al. Among authors: su cy. Nat Genet. 2025 Feb;57(2):345-357. doi: 10.1038/s41588-024-02052-7. Epub 2025 Jan 24. Nat Genet. 2025. PMID: 39856218 Free PMC article.
CD5L associates with IgM via the J chain.
Wang Y, Su C, Ji C, Xiao J. Wang Y, et al. Among authors: su c. Nat Commun. 2024 Sep 27;15(1):8397. doi: 10.1038/s41467-024-52175-y. Nat Commun. 2024. PMID: 39333069 Free PMC article.
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials.
Zhao S, Cheng Y, Wang Q, Li X, Liao J, Rodon J, Meng X, Luo Y, Chen Z, Wang W, Yi T, Li Y, Yin Y, Xu H, Yu G, Mi Y, Fan Y, Wainberg ZA, Wang X, Su C, Yu Q, Lai S, Sun L, Zhuang W, Wang X, Yang J, Li Y, Ge J, Li J, Zhang L, Fang W. Zhao S, et al. Among authors: su c. Nat Med. 2025 Apr 10. doi: 10.1038/s41591-025-03638-2. Online ahead of print. Nat Med. 2025. PMID: 40210967
9,064 results